$782 Million is the total value of SABBY MANAGEMENT, LLC's 124 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 58.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | SPDR S&P 500put | $117,044,000 | +79.8% | 4,026 | +67.8% | 14.98% | +48.9% | |
| Buy | SPDR S&P 500call | $116,317,000 | +114.5% | 4,001 | +100.2% | 14.88% | +77.6% | |
| New | ISHARES RUSSELL 2000put | $67,420,000 | – | 4,000 | +100.0% | 8.63% | – | |
| Sell | BIOGEN INCput | $61,723,000 | -1.9% | 1,747 | -28.7% | 7.90% | -18.7% | |
| Sell | ISHARES RUSSELL 2000call | $35,648,000 | -42.0% | 2,115 | -43.6% | 4.56% | -51.9% | |
| Sell | ESPERION THERAPEUTICS INCput | $29,692,000 | +8.4% | 6,692 | -4.2% | 3.80% | -10.2% | |
| Buy | NEKTAR THERAPEUTICSput | $28,560,000 | +96.5% | 4,685 | +57.4% | 3.66% | +62.7% | |
| Sell | SAREPTA THERAPEUTICS INCcall | $28,200,000 | +0.8% | 1,746 | -17.5% | 3.61% | -16.6% | |
| Buy | SPDR S&P BIOTECHcall | $18,014,000 | +32.4% | 1,879 | +31.5% | 2.30% | +9.7% | |
| NKTR | Buy | NEKTAR THERAPEUTICS | $18,008,000 | +52.4% | 295,405 | +22.1% | 2.30% | +26.2% |
| Sell | AMARIN CORPORATION PLCcall | $16,000,000 | +383.7% | 9,834 | -8.2% | 2.05% | +300.6% | |
| New | TILRAY INCput | $15,252,000 | – | 1,062 | +100.0% | 1.95% | – | |
| Buy | ASTRAZENECA PLCcall | $15,155,000 | +58.0% | 3,830 | +40.2% | 1.94% | +30.8% | |
| SAREPTA THERAPEUTICS INCput | $14,665,000 | +22.2% | 908 | 0.0% | 1.88% | +1.2% | ||
| Buy | ASTRAZENECA PLCput | $14,265,000 | +20.7% | 3,605 | +7.1% | 1.82% | 0.0% | |
| Buy | ZOGENIX INCcall | $13,084,000 | +71.8% | 2,638 | +53.1% | 1.67% | +42.2% | |
| BIIB | Sell | BIOGEN INC | $12,555,000 | -71.6% | 35,534 | -76.6% | 1.61% | -76.4% |
| ZSAN | Sell | ZOSANO PHARMA CORP | $12,439,000 | +508.9% | 250,783 | -49.9% | 1.59% | +403.8% |
| ODT | Sell | ODONATE THERAPEUTICS INC | $10,164,000 | -20.4% | 523,653 | -9.5% | 1.30% | -34.1% |
| Buy | FIBROGEN INCput | $8,772,000 | +283.9% | 1,444 | +295.6% | 1.12% | +217.8% | |
| XERS | Buy | XERIS PARMACEUTICALS INC | $8,560,000 | +0.7% | 486,938 | +8.8% | 1.10% | -16.6% |
| New | VIKING THERAPEUTICS INCput | $6,747,000 | – | 3,873 | +100.0% | 0.86% | – | |
| UMRX | Sell | UNUM THERAPEUTICS INC | $5,577,000 | -33.1% | 541,420 | -6.9% | 0.71% | -44.6% |
| New | FIBROGEN INCcall | $5,565,000 | – | 916 | +100.0% | 0.71% | – | |
| Sell | SANGAMO THERAPEUTICS INCput | $5,251,000 | +4.5% | 3,098 | -12.5% | 0.67% | -13.5% | |
| Buy | SPDR S&P BIOTECHput | $5,177,000 | +8.8% | 540 | +8.0% | 0.66% | -9.9% | |
| Buy | GLOBAL BLOOD THERAPEUTICS INCcall | $4,986,000 | +31.9% | 1,312 | +56.9% | 0.64% | +9.2% | |
| ESPR | Sell | ESPERION THERAPEUTICS INC | $4,453,000 | -23.6% | 100,369 | -32.5% | 0.57% | -36.7% |
| Sell | AVEO PHARMACEUTICALS INCcall | $4,032,000 | +46.1% | 12,182 | -0.3% | 0.52% | +21.1% | |
| ORMP | New | ORAMED PHARMACEUTICALS INC | $3,876,000 | – | 801,242 | +100.0% | 0.50% | – |
| OPHT | Buy | OPHTHOTECH CORP | $3,820,000 | +6.8% | 1,618,820 | +23.6% | 0.49% | -11.6% |
| Sell | NEKTAR THERAPEUTICScall | $3,609,000 | +13.0% | 592 | -9.5% | 0.46% | -6.3% | |
| BCLI | Sell | BRAINSTORM CELL THERAPEUTICS INC | $3,465,000 | -4.4% | 906,956 | -2.4% | 0.44% | -20.9% |
| VBLT | Buy | VASCULAR BIOGENICS LTD | $3,454,000 | -15.4% | 2,125,738 | +14.5% | 0.44% | -30.0% |
| ONS | Sell | ONCOBIOLOGICS INC | $3,318,000 | +6.3% | 3,354,909 | -9.1% | 0.42% | -11.8% |
| Buy | MADRIGAL PHARMACEUTICALS INCcall | $3,298,000 | +47.4% | 154 | +92.5% | 0.42% | +22.0% | |
| VKTX | New | VIKING THERAPEUTICS INC | $2,848,000 | – | 163,463 | +100.0% | 0.36% | – |
| Buy | AMICUS THERAPEUTICS INCcall | $2,841,000 | +307.6% | 2,350 | +426.9% | 0.36% | +237.0% | |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $2,660,000 | +11.3% | 156,913 | -6.7% | 0.34% | -7.9% |
| New | ALKERMES PLCcall | $2,423,000 | – | 571 | +100.0% | 0.31% | – | |
| Buy | AMICUS THERAPEUTICS INCput | $2,002,000 | -10.7% | 1,656 | +15.3% | 0.26% | -26.2% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $1,874,000 | +212.9% | 155,044 | +304.4% | 0.24% | +158.1% |
| GNPX | Buy | GENPREX INC | $1,664,000 | -47.6% | 733,200 | +77.0% | 0.21% | -56.5% |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $1,631,000 | -11.3% | 755,312 | -3.9% | 0.21% | -26.4% |
| Buy | MARINUS PHARMACEUTICALS INCcall | $1,595,000 | +78.0% | 1,595 | +25.8% | 0.20% | +47.8% | |
| Sell | ADVERUM BIOTECHNOLOGIES INCcall | $1,349,000 | -31.3% | 2,230 | -39.8% | 0.17% | -42.9% | |
| RKDA | Buy | ARCADIA BIOSCIENCES INC | $1,355,000 | +35.0% | 277,181 | +127.8% | 0.17% | +11.6% |
| CYTR | Sell | CYTRX CORP | $1,333,000 | -29.5% | 1,269,731 | -24.2% | 0.17% | -41.4% |
| Buy | MANNKIND CORPput | $1,309,000 | -10.2% | 7,154 | +57.2% | 0.17% | -25.8% | |
| APTX | Sell | APTINYX INC | $1,188,000 | +17.4% | 41,037 | -2.0% | 0.15% | -2.6% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $1,132,000 | +10.7% | 94,224 | +24.3% | 0.14% | -8.2% |
| MDGS | New | MEDIGUS LTDads | $1,006,000 | – | 296,712 | +100.0% | 0.13% | – |
| ISR | New | ISORAY INC | $999,000 | – | 1,925,487 | +100.0% | 0.13% | – |
| MKGI | New | MONAKER GROUP INC | $956,000 | – | 444,572 | +100.0% | 0.12% | – |
| Sell | VIKING THERAPEUTICS INCcall | $941,000 | -9.3% | 540 | -50.6% | 0.12% | -25.0% | |
| MDGSW | New | MEDIGUS LTD*w | $926,000 | – | 1,268,146 | +100.0% | 0.12% | – |
| Buy | SYNERGY PHARMACEUTICALS INCcall | $915,000 | +0.1% | 5,382 | +2.4% | 0.12% | -17.0% | |
| PAVMZ | Sell | PAVMED INC*w | $915,000 | +30.0% | 1,946,838 | -8.5% | 0.12% | +7.3% |
| Sell | INSMED INCput | $833,000 | -78.8% | 412 | -75.2% | 0.11% | -82.4% | |
| Sell | AMARIN CORPORATION PLCput | $828,000 | +141.4% | 509 | -54.1% | 0.11% | +100.0% | |
| ATOS | Buy | ATOSSA GENETICS INC | $814,000 | +8.5% | 465,039 | +36.5% | 0.10% | -10.3% |
| RIBT | New | RICEBRAN TECHNOLOGIES | $807,000 | – | 281,061 | +100.0% | 0.10% | – |
| OPNT | New | OPIANT PHARMACEUTICALS INC | $781,000 | – | 43,736 | +100.0% | 0.10% | – |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $766,000 | -24.5% | 76,740 | +54.0% | 0.10% | -37.6% |
| FGEN | Buy | FIBROGEN INC | $730,000 | +11.1% | 12,019 | +14.6% | 0.09% | -8.8% |
| NOVN | Sell | NOVAN INC | $700,000 | -48.6% | 250,958 | -45.8% | 0.09% | -57.1% |
| SNES | New | SENESTECH INC | $675,000 | – | 978,702 | +100.0% | 0.09% | – |
| EYEN | Buy | EYENOVIA INC | $657,000 | -22.2% | 163,357 | +21.8% | 0.08% | -35.9% |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $599,000 | -78.3% | 44,136 | -81.0% | 0.08% | -82.0% |
| New | ALDEYRA THERAPEUTICS INCcall | $589,000 | – | 427 | +100.0% | 0.08% | – | |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $556,000 | -48.8% | 278,184 | -45.7% | 0.07% | -57.7% |
| SCON | New | SUPERCONDUCTOR TECHNOLOGIES INC | $533,000 | – | 287,948 | +100.0% | 0.07% | – |
| CHFS | Sell | CHF SOLUTIONS INC | $499,000 | -40.4% | 423,218 | -6.9% | 0.06% | -50.4% |
| NURO | Buy | NEUROMETRIX INC | $496,000 | +10.0% | 372,913 | +8.4% | 0.06% | -10.0% |
| PTI | New | PROTEOSTASIS THERAPEUTICS INC | $482,000 | – | 199,900 | +100.0% | 0.06% | – |
| Buy | SOPHIRIS BIO INCput | $440,000 | +780.0% | 1,578 | +3.9% | 0.06% | +600.0% | |
| BPTH | New | BIO PATH HOLDINGS INC | $437,000 | – | 970,877 | +100.0% | 0.06% | – |
| APOP | Sell | CELLECT BIOTECHNOLOGY LTD | $412,000 | -48.4% | 86,517 | -22.4% | 0.05% | -56.9% |
| New | MICROBOT MED INC | $405,000 | – | 54,518 | +100.0% | 0.05% | – | |
| Buy | SESEN BIO INCput | $392,000 | +100.0% | 1,823 | +81.8% | 0.05% | +66.7% | |
| BIOC | New | BIOCEPT INC | $392,000 | – | 142,417 | +100.0% | 0.05% | – |
| Sell | FUELCELL ENERGY INCput | $372,000 | -46.5% | 3,480 | -33.9% | 0.05% | -55.1% | |
| CHEK | Buy | CHECK CAP LTD | $363,000 | +37.5% | 90,771 | +39.3% | 0.05% | +12.2% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $327,000 | -1.2% | 135,272 | -7.7% | 0.04% | -17.6% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $321,000 | – | 1,500 | +100.0% | 0.04% | – |
| TTNP | New | TITAN PHARMACEUTICALS INC | $314,000 | – | 1,518,294 | +100.0% | 0.04% | – |
| INSM | Sell | INSMED INC | $303,000 | -28.0% | 15,000 | -15.7% | 0.04% | -40.0% |
| OPHTHOTECH CORPcall | $287,000 | -13.6% | 1,217 | 0.0% | 0.04% | -27.5% | ||
| HEB | Sell | HEMISPHERX BIOPHARMA INC | $263,000 | -57.6% | 1,143,632 | -41.0% | 0.03% | -64.6% |
| Sell | DBV TECHNOLOGIES SAcall | $261,000 | -51.1% | 116 | -58.1% | 0.03% | -60.2% | |
| New | CONATUS PHARMACEUTICALS INCcall | $253,000 | – | 437 | +100.0% | 0.03% | – | |
| NSPR | Buy | INSPIREMD INC | $236,000 | +52.3% | 1,071,004 | +71.8% | 0.03% | +25.0% |
| CHEKZ | Sell | CHECK CAP LTD*w | $230,000 | -46.3% | 306,878 | -51.2% | 0.03% | -56.1% |
| RTTR | New | RITTER PHARMACEUTICALS INC | $186,000 | – | 100,000 | +100.0% | 0.02% | – |
| OVAS | Sell | OVASCIENCE INC | $187,000 | -78.4% | 255,803 | -73.2% | 0.02% | -82.1% |
| Sell | SUNESIS PHARMACEUTICALS INCcall | $191,000 | -60.9% | 955 | -58.5% | 0.02% | -68.0% | |
| DRRX | Buy | DURECT CORP | $145,000 | -13.7% | 131,900 | +22.5% | 0.02% | -26.9% |
| APDNW | Sell | APPLIED DNA SCIENCES*w | $136,000 | -26.9% | 616,043 | -7.2% | 0.02% | -41.4% |
| TROV | Sell | TROVAGENE INC | $125,000 | -78.4% | 153,638 | -79.5% | 0.02% | -82.0% |
| New | ADVERUM BIOTECHNOLOGIES INCput | $102,000 | – | 168 | +100.0% | 0.01% | – | |
| AYTU | New | AYTU BIOSCIENCE INC | $98,000 | – | 35,466 | +100.0% | 0.01% | – |
| CVM | Buy | CEL-SCI CORP | $101,000 | +573.3% | 24,816 | +49.6% | 0.01% | +550.0% |
| SLS | New | SELLAS LIFE SCIENCES GROUP INC | $96,000 | – | 78,294 | +100.0% | 0.01% | – |
| SGLBW | Sell | SIGMA LABS INC*w | $87,000 | -13.0% | 280,529 | -1.3% | 0.01% | -26.7% |
| Buy | DURECT CORPcall | $69,000 | -27.4% | 627 | +3.3% | 0.01% | -40.0% | |
| YTEN | YIELD10 BIOSCIENCE INC | $68,000 | +1.5% | 47,740 | 0.0% | 0.01% | -10.0% | |
| ONTXW | Buy | ONCONOVA THERAPEUTICS INC*w | $67,000 | +737.5% | 665,470 | +1.8% | 0.01% | +800.0% |
| RXIIW | Sell | RXI PHARMACEUTICALS*w | $68,000 | +38.8% | 195,259 | -0.5% | 0.01% | +12.5% |
| SBOT | New | STELLAR BIOTECHNOLOGIES INC | $65,000 | – | 46,859 | +100.0% | 0.01% | – |
| SCYX | New | SCYNEXIS INC | $50,000 | – | 41,579 | +100.0% | 0.01% | – |
| KTOV | New | KITOV PHARMA LTDadr | $47,000 | – | 27,043 | +100.0% | 0.01% | – |
| Buy | PLURISTEM THERAPEUTICS INCput | $41,000 | +17.1% | 312 | +8.3% | 0.01% | 0.0% | |
| SOLOW | New | ELECTRAMECCANICA VEHICLES CORP*w | $38,000 | – | 101,000 | +100.0% | 0.01% | – |
| OPHTHOTECH CORPput | $31,000 | -13.9% | 133 | 0.0% | 0.00% | -33.3% | ||
| New | CORMEDIX INCput | $28,000 | – | 287 | +100.0% | 0.00% | – | |
| OPGN | Sell | OPGEN INC COM NEW | $34,000 | -92.1% | 16,958 | -93.0% | 0.00% | -94.0% |
| CTXR | Sell | CITIUS PHARMACEUTICALS INC | $20,000 | -97.9% | 11,564 | -97.2% | 0.00% | -97.9% |
| RSLS | Buy | RESHAPE LIFESCIENCES INC | $20,000 | -96.3% | 461,704 | +96.1% | 0.00% | -96.4% |
| BNTCW | Sell | BENITEC BIOPHARMA LTD*w | $7,000 | -12.5% | 58,050 | -23.5% | 0.00% | 0.0% |
| NSPRZ | Sell | INSPIREMD INC*w | $7,000 | -80.6% | 1,847,636 | -6.8% | 0.00% | -83.3% |
| KOOL | Sell | CESCA THERAPEUTICS INC | $6,000 | -90.2% | 19,988 | -86.4% | 0.00% | -88.9% |
| New | HELIOS AND MATHESON ANALYTICS INCcall | $0 | – | 125 | +100.0% | 0.00% | – | |
| NSPRW | Sell | INSPIREMD INC*w | $1,000 | -87.5% | 498,797 | -40.5% | 0.00% | -100.0% |
| CYTXW | Sell | CYTORI THERAPEUTICS*w | $0 | -100.0% | 37,793 | -87.4% | 0.00% | – |
| EGLTQ | Exit | EGALET CORP | $0 | – | -2,134 | -100.0% | 0.00% | – |
| IMUCW | Exit | IMMUNOCELLULAR THERAPEUTICS*w | $0 | – | -74,443 | -100.0% | 0.00% | – |
| Exit | HELIOS AND MATHESON ANALYTICS INCput | $0 | – | -246 | -100.0% | -0.00% | – | |
| SCON | Exit | SUPERCONDUCTOR TECHNOLOGIES | $0 | – | -22,748 | -100.0% | -0.00% | – |
| ROSGQ | Exit | ROSETTA GENOMICS LTD | $0 | – | -941,693 | -100.0% | -0.00% | – |
| ONTX | Exit | ONCONOVA THERAPEUTICS | $0 | – | -63,218 | -100.0% | -0.00% | – |
| Exit | HELIOS AND MATHESON ANALYTICS INCcall | $0 | – | -965 | -100.0% | -0.01% | – | |
| BIOC | Exit | BIOCEPT INC | $0 | – | -177,601 | -100.0% | -0.01% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| FCEL | Exit | FUELCELL ENERGY INC | $0 | – | -30,140 | -100.0% | -0.01% | – |
| Exit | AFFIMED N.V.put | $0 | – | -454 | -100.0% | -0.01% | – | |
| GALT | Exit | GALECTIN THERAPEUTICS INC | $0 | – | -14,029 | -100.0% | -0.01% | – |
| Exit | AFFIMED N.V.call | $0 | – | -543 | -100.0% | -0.01% | – | |
| Exit | AQUINOX PHARMACEUTICALS INCput | $0 | – | -456 | -100.0% | -0.02% | – | |
| CANF | Exit | CAN FITE BIOPHARMA LTD | $0 | – | -109,905 | -100.0% | -0.02% | – |
| AFMD | Exit | AFFIMED N.V. | $0 | – | -86,386 | -100.0% | -0.02% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -27,263 | -100.0% | -0.02% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -12,000 | -100.0% | -0.02% | – |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -55,203 | -100.0% | -0.02% | – |
| AYTU | Exit | AYTU BIOSCIENCE INC | $0 | – | -709,312 | -100.0% | -0.03% | – |
| EARS | Exit | AURIS MEDICAL HOLDING AG | $0 | – | -263,625 | -100.0% | -0.03% | – |
| HMNY | Exit | HELIOS AND MATHESON ANALYTICS INC | $0 | – | -834,318 | -100.0% | -0.04% | – |
| INPX | Exit | INPIXON | $0 | – | -1,685,814 | -100.0% | -0.04% | – |
| ATEC | Exit | ALPHATEC HOLDINGS INC | $0 | – | -94,216 | -100.0% | -0.04% | – |
| NVIV | Exit | INVIVO THERAPEUTICS HLDGS CORP | $0 | – | -169,661 | -100.0% | -0.04% | – |
| RXII | Exit | RXI PHARMACEUTICALS | $0 | – | -168,462 | -100.0% | -0.05% | – |
| APDN | Exit | APPLIED DNA SCIENCES INC | $0 | – | -277,319 | -100.0% | -0.05% | – |
| MBOT | Exit | MICROBOT MED | $0 | – | -494,686 | -100.0% | -0.06% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -220,600 | -100.0% | -0.07% | – |
| Exit | ZOGENIX INCput | $0 | – | -127 | -100.0% | -0.09% | – | |
| Exit | AMYRIS INCput | $0 | – | -990 | -100.0% | -0.10% | – | |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -42,507 | -100.0% | -0.11% | – |
| IDXG | Exit | INTERPACE DIAGNOSTICS GROUP INC | $0 | – | -932,954 | -100.0% | -0.13% | – |
| Exit | BIOGEN INCcall | $0 | – | -30 | -100.0% | -0.14% | – | |
| Exit | SANGAMO THERAPEUTICS INCcall | $0 | – | -878 | -100.0% | -0.19% | – | |
| PAVM | Exit | PAVMED INC | $0 | – | -1,398,850 | -100.0% | -0.20% | – |
| Exit | SPARK THERAPEUTICS INCput | $0 | – | -160 | -100.0% | -0.20% | – | |
| Exit | ESPERION THERAPEUTICS INCcall | $0 | – | -370 | -100.0% | -0.22% | – | |
| Exit | TESARO INCcall | $0 | – | -331 | -100.0% | -0.23% | – | |
| AZN | Exit | ASTRAZENECA PLCadr | $0 | – | -68,464 | -100.0% | -0.37% | – |
| Exit | INCYTE CORPput | $0 | – | -406 | -100.0% | -0.42% | – | |
| INCY | Exit | INCYTE CORP | $0 | – | -41,419 | -100.0% | -0.43% | – |
| SSKN | Exit | STRATA SKIN SCIENCES INC | $0 | – | -1,682,279 | -100.0% | -0.53% | – |
| Exit | SPARK THERAPEUTICS INCcall | $0 | – | -547 | -100.0% | -0.70% | – | |
| Exit | NOVO NORDISK A/Scall | $0 | – | -3,972 | -100.0% | -2.83% | – | |
| NVO | Exit | NOVO NORDISK A/Sadr | $0 | – | -429,355 | -100.0% | -3.06% | – |
| Exit | NOVO NORDISK A/Sput | $0 | – | -6,221 | -100.0% | -4.43% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.